A New Era in Hair Regeneration
Low-Level Laser Therapy (LLLT) has been studied for decades as a safe, non-invasive method to encourage hair regrowth. Traditionally, research focused on the effects of a single light wavelength, usually in the red or near-infrared range. In early 2025, a team of researchers from the Central Hospital of Dalian University of Technology and other institutions in China published an important study in the Journal of Biophotonics. They tested the effects of combining two light wavelengths. Their results suggest that dual-wavelength light could be the next step for LLLT in treating hair loss.
The Basics of LLLT
LLLT works by using low-intensity light to stimulate skin cells. When hair follicles absorb certain wavelengths of light, cellular energy production increases and blood flow improves. This combination helps extend the hair growth phase and may reactivate dormant follicles. Importantly, the light levels used are not strong enough to cause burns or tissue damage, making LLLT a gentle and safe choice compared to surgical or pharmaceutical options.
Why Dual-Wavelength Therapy Matters
Most earlier devices used a single wavelength, such as 650 or 670 nanometers, to target hair follicle cells. While this showed benefits, the Dalian research team wanted to see if using two different wavelengths—one in the visible red range and another in the near-infrared range—could improve outcomes. The idea is straightforward: red light reaches surface-level follicle cells, while near-infrared light penetrates deeper layers of the scalp. Together, they could stimulate a wider range of cells and biological processes.
The Study at a Glance
The researchers tested 32 laboratory mice. The mice had the hair on their backs shaved and were then divided into groups receiving either:
- A single wavelength of 670 nm light
- A dual combination of 680 nm and 780 nm light
- A dual combination of 680 nm and 880 nm light
- No light treatment (control group)
The treatments were given daily for 14 days, with each session lasting 20 minutes. At the end of the study, hair regrowth was assessed visually through photographs and under a microscope with tissue samples.
What the Researchers Found
The results were impressive. Mice treated with dual-wavelength light (680 + 780 nm or 680 + 880 nm) showed significantly denser and more uniform hair regrowth compared to both the single-wavelength group and the untreated control group. Photographic analysis revealed larger regrowth areas, while histological examination confirmed that these mice had more hair follicles in active growth phases. Interestingly, while the number of follicles increased, their diameter did not change significantly between groups. This suggests that dual-wavelength therapy mainly boosts the number of growing hairs rather than the size of each follicle.
Understanding the Science Behind It
The study provides several reasons why combining wavelengths works better.
- Deeper penetration: Near-infrared light (such as 780 or 880 nm) penetrates deeper than red light, stimulating follicle stem cells located further beneath the skin surface.
- Broader cellular response: Different wavelengths trigger different cellular signals. Using two wavelengths covers a wider biological spectrum, reducing the chance that cells fail to respond due to wavelength-specific sensitivity.
- Improved nutrient delivery: LLLT also increases local blood flow, ensuring follicles receive more oxygen and nutrients, which are essential for growth.
These mechanisms create a combined effect that outperforms single-wavelength treatments.
What This Means for Patients
Although this research was conducted on mice, it suggests a promising direction for human treatments. Many commercial LLLT devices currently use single wavelengths. These findings indicate that future devices may include dual or even multiple wavelength combinations to enhance effectiveness. For patients, this could lead to faster, denser, and more reliable regrowth with at-home caps or in-clinic laser sessions.
Safety and Limitations
One of the most reassuring aspects of LLLT is its safety profile. Unlike surgical hair transplants, it does not involve cutting or scarring. Unlike medications such as finasteride or minoxidil, it does not carry systemic side effects like hormonal changes or skin irritation for most users. In this study, the mice experienced no burns or thermal damage from the therapy, confirming that the effects came from cellular stimulation rather than heat.
However, there are limitations. Mice are not people, and while animal studies provide useful insights, clinical trials in humans are still needed to confirm the exact effectiveness of dual-wavelength therapy. Additionally, hair loss has many causes, from genetics to hormonal changes to autoimmune conditions, and LLLT may not work equally well for all types.
Looking Toward the Future
This new research indicates that light-based therapies are evolving into more advanced treatments. By fine-tuning the combinations of wavelengths, scientists may eventually create personalized protocols for patients, adjusting treatments to target specific hair loss patterns or scalp conditions. The ongoing challenge is to standardize treatment parameters since current devices vary widely in wavelength, power, and duration, leading to inconsistent results across studies.
Conclusion
The study by Gao and colleagues, published in the Journal of Biophotonics in 2025, provides strong evidence that dual-wavelength LLLT significantly improves hair regrowth compared to traditional single-wavelength approaches. While more clinical research is needed in humans, the findings point toward a future where hair restoration can be safer, more effective, and more scientifically grounded. For those exploring non-invasive options, dual-wavelength laser therapy represents one of the most exciting frontiers in the fight against hair loss.
Reference
Gao, H., Liu, Y., Liu, Z., Wang, P., Qin, Z., Liao, S., Mo, J., Wang, L. and Chui, H.-C. (2025), Enhanced Hair Regrowth Through Dual-Wavelength Low-Level Laser Therapy: A Comparative Study on Mice. J. Biophotonics, 18: e202400523. https://doi.org/10.1002/jbio.202400523